Share Name Share Symbol Market Type Share ISIN Share Description
Consort Med. LSE:CSRT London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +8.00p +0.79% 1,024.00p 1,014.00p 1,019.00p 1,030.00p 1,010.00p 1,013.00p 14,707.00 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 276.9 11.2 30.7 33.4 503.09

Consort Med. (CSRT) Latest News (1)

More Consort Med. News
Consort Med. Takeover Rumours

Consort Med. (CSRT) Share Charts

1 Year Consort Med. Chart

1 Year Consort Med. Chart

1 Month Consort Med. Chart

1 Month Consort Med. Chart

Intraday Consort Med. Chart

Intraday Consort Med. Chart

Consort Med. (CSRT) Discussions and Chat

Consort Med. Forums and Chat

Date Time Title Posts
07/9/201619:01Consort Medical - Medical Devices108.00
17/11/201414:19Aesica acquisition bolsters growth prospects-

Add a New Thread

Consort Med. (CSRT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Consort Med. trades in real-time

Consort Med. (CSRT) Top Chat Posts

Consort Med. Daily Update: Consort Med. is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker CSRT. The last closing price for Consort Med. was 1,016p.
Consort Med. has a 4 week average price of 1,066.25p and a 12 week average price of 1,096.97p.
The 1 year high share price is 1,175p while the 1 year low share price is currently 935p.
There are currently 49,130,358 shares in issue and the average daily traded volume is 52,858 shares. The market capitalisation of Consort Med. is £503,094,865.92.
cerrito: Not had time to have a good look at yesterday's figures but note the following comment from The Independant Consort Medical Our view: Buy Share price: 530p (+32p) The market was certainly pleased with Consort Medical's update yesterday. The medical-devices firm issued half-yearly figures, which sent its stock up sharply on the day. Revenues in the six months to the end of October were up 5 per cent at nearly £69m, while pre-tax profits were up more than 50 per cent (profits before tax and special items were up 22 per cent). The group, which maintained its interim dividend at 7p per share, was boosted by strong volumes at its Bespak unit's core respiratory division. Net debt was up, as Consort pressed on with its planned investment activities, but, at 1.3 times earnings before interest, tax, depreciation and amortisation, it remains within the company's borrowing covenants and facilities. So, not much to fault. Although the economy both here and in many other parts of the world is not doing great, Consort remains confident, which shouldn't come as a surprise given the size and the trends in the broader market for respiratory illnesses. Not that the company is being complacent; yesterday, it also announced a contract to develop a device that looks like a cigarette and acts as a replacement for nicotine. This is also a growing area, and Consort's efforts in this direction are encouraging. At just under 11 times forward earnings, with a dividend yield of just under 4 per cent, the stock is also affordable.
Consort Med. share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161209 19:19:35